This study is an investigator initiated, single site, University of Pittsburgh, prospective,
parallel group, randomized controlled trial comparing SynePure Wound Cleanser and Catasyn
Advanced Technology Hydrogel (intervention group) to the current gold standard treatment
Silvadene (control group). Both groups will receive the same care other than the treating
agent. Subjects will be recruited form the UPMC Mercy Burn Center adult patient pool who have
sustained superficial partial-thickness burn wounds that comprise less than or equal to 10%
of total body surface area (TBSA)